Crestchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Financial Results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crestchem Ltd has announced a Board meeting on May 26, 2026, to consider audited standalone financial results for Q4 and FY ended March 31, 2026, and a potential final dividend for shareholders' approval at the 34th AGM. The board will also consider forming a new subsidiary — Oleo Bioscience Private Limited — incorporated on March 31, 2026 at Bangalore, which has not yet commenced any activity. Three related party appointments are on the agenda: reappointment of MD Dipak Narendraprasad Patel and two other related parties (Parul Dipak Patel and Tansi Nirmit Patel) under Section 188 of the Companies Act, 2013. The board also proposes to invest up to Rs 2.25 crore in the new subsidiary. The trading window is already closed from April 1, 2026 until 48 hours after results are made public.
The formation of a new subsidiary and planned investment of up to Rs 2.25 crore indicate expansion into a new business line (biosciences), though the entity has not yet started operations. The related party reappointments under Section 188 require careful shareholder scrutiny. Overall, this is a routine pre-results announcement with no immediate negative signal.